Human papillomavirus subtypes in oral lesions compared to healthy oral mucosa

Journal of Clinical Virology

Volumn 53, Issue 4, 2012, Pages 364-366

  Kristoffersen, A K ^a   Enersen, M ^a   Kverndokk, E ^a   Sunde, P T ^a   Landin, M ^a   Solheim, T ^a   Olsen, I ^a   Grinde, B ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Human papillomavirus; Leukoplakia; Oral carcinoma; PCR; Sequencing; Squamous cell carcinoma

Indexed keywords

BETA GLOBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH LESION; MOUTH MUCOSA; ORAL BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS CAPSID; VIRUS CHARACTERIZATION; VIRUS EXAMINATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; FEMALE; GENOTYPE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84858150694     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.12.023     Document Type: Article

References (26)

1. Acay R.R., dos Santos E., de Sousa S.O. Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions. Oral Oncol 2008, 44:698-702.
2. Szarka K., Tar I., Feher E., Gall T., Kis A., Toth E.D., et al. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential. Oral Microbiol Immunol 2009, 24(4):314-318.
3. Llamas-Martínez S., Esparza-Gómez G., Campo-Trapero J., Cancela-Rodríguez P., Bascones-Martínez A., Moreno-López L.A., et al. Genotypic determination by PCR-RFLP of human papillomavirus in normal oral mucosa, oral leukoplakia and oral squamous cell carcinoma samples in Madrid (Spain). Anticancer Res 2008, 28(6A):3733-3741.
4. Cianfriglia F., Di Gregorio D.A., Cianfriglia C., Marandino F., Perrone Donnorso R., Vocaturo A. Incidence of human papillomavirus infection in oral leukoplakia. J Exp Clin Cancer Res 2006, 25(1):21-28.
5. Bagan J.V., Jimenez Y., Murillo J., Gavalda C., Poveda R., Scully C., et al. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection. J Oral Maxillofac Surg 2007, 65(1):46-49.
6. Yang S.W., Lee Y.S., Chen T.A., Wu C.J., Tsai C.N. Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation. Cancer Epidemiol 2009, 33:118-122.
7. Maitland N.J., Cox M.F., Lynas C., Prime S.S., Meanwell C.A., Scully C. Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer 1987, 56:245-250.
8. Koyama K., Uobe K., Tanaka A. Highly sensitive detection of HPV-DNA in paraffin sections of human oral carcinomas. J Oral Pathol Med 2007, 36(1):18-24.
9. Varnai A.D., Bollmann M., Bankfalvi A., Kovacs K., Heller H., Schmitt C., et al. The prevalence and distribution of human papillomavirus genotypes in oral epithelial hyperplasia: proposal of a concept. J Oral Pathol Med 2009, 38:181-187.
10. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995, 76(Pt4):1057-1062.
11. Dabic M.M., Hlupic L., Babic D., Jukic S., Seiwerth S. Comparison of polymerase chain reaction and catalyzed signal amplification in situ hybridization methods for human papillomavirus detection in paraffin-embedded cervical preneoplastic and neoplastic lesions. Arch Med Res 2004, 35:511-516.
12. Gheit T., Landi S., Gemignani F., Snijders P.J., Vaccarella S., Franceschi S., et al. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006, 44:2025-2031.
13. Schmitt M., Dondog B., Waterboer T., Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol 2008, 46:1050-1059.
14. De Marco F., Di Carlo A., Poggiali F., Muller A., Marcante M.L. Detection of HPV in genital condylomata: correlation between viral load and clinical outcome. J Exp Clin Cancer Res 2001, 20:377-383.
15. Depuydt C.E., Boulet G.A., Horvath C.A., Benoy I.H., Vereecken A.J., Bogers J.J. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 2007, 11:881-891.
16. Hesselink A.T., Heideman D.A., Berkhof J., Topal F., Pol R.P., Meijer C.J., et al. Comparison of the clinical performance of the PapilloCheck HPV detection with GP5+/6+-PCR-EIA in population-based cervical screening. J Clin Microbiol 2010, 48(3):797-801.
17. Schmitt M., Dondog B., Waterboer T., Pawlita M., Tommasino M., Gheit T. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 2010, 48(1):143-149.
18. Hormia M., Willberg J., Ruokonen H., Syrjanen S. Marginal periodontium as a potential reservoir of human papillomavirus in oral mucosa. J Periodontol 2005, 76(3):358-363.
19. Szeps M., Dahlgren I., Aaltonen L.M., Öhd J., Kanter-Lewnshon L., Dahlstrand H., et al. Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment. J Gen Virol 2005, 86(Pt 6):1695-1702.
20. Gillio-Tos A., De Marco L., Ghisetti V., Snijders P.J., Segnan N., Ronco G., et al. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits. J Clin Virol 2006, 36(2):126-132.
21. Lawson W., Schlecht N.F., Brandwein-Gensler M. The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol 2008, 2(2):49-59.
22. Hannisdal K., Schjolberg A., De Angelis P.M., Boysen M., Clausen O.P. Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway. Acta Otolaryngol 2010, 130(2):293-299.
23. Nasman A., Attner P., Hammarstedt L., Du J., Eriksson M., Giraud G., et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer 2009, 125(2):362-366.
24. Machado J., Reis P.P., Zhang T., Simpson C., Xu W., Perez-Ordonez, et al. Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol 2010, 2:1-6.
25. Pavia M., Pileggi C., Nobile C.G., Angelillo I.F. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr 2006, 83(5):1126-1134.
26. Johnson N.W., Warnakulasuriya S., Gupta P.C., Dimba E., Chindia M., Otoh E.C., et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res 2011, 23(2):237-246.